Clinical Trials Browser

Phase 2 × Breast Neoplasms × nimotuzumab × Clear all

NCT01939054 2015-06-04

Nimotuzumab Plus Docetaxel and Capecitabine Versus Docetaxel and Capecitabine in the Treatment of Breast Cancer Patients

Phase 2 Unknown

Breast Neoplasms